Results for natalizumabs translation from Latvian to English

natalizumabs
natalizumab

tysabri natalizumabs
tysabri natalizumab

aktīvā viela ir natalizumabs.
the active substance is natalizumab.

natalizumabs izdalās mātes pienā.
natalizumab is excreted in human milk.

tysabri aktīvā viela natalizumabs ir monoklonāla antiviela.
the active substance in tysabri, natalizumab, is a monoclonal antibody.

placebo/natalizumabs 300 mg i.v. reizi 4 nedēļās
placebo / natalizumab 300 mg i.v. every 4 weeks

natalizumabs, tysabri akt v viela, ir monoklon la antiviela.
the active substance in tysabri, natalizumab, is a monoclonal antibody.

tysabri aktīvā sastāvdaļa ir natalizumabs, olbaltumviela, līdzīga jūsu organisma olbaltumvielām.
in tysabri the active ingredient is natalizumab, a protein similar to your own antibodies.

maz ticams, ka natalizumabs ietekmēs cilvēku fertilitāti, lietojot maksimālo ieteicamo devu.
it is considered unlikely that natalizumab will affect fertility performance in humans following the maximum recommended dose.

tiek uzskatīts, ka, piesaistoties integrīnam, natalizumabs aptur leikocītu iekļūšanu no asinīm smadzenēs.
by attaching to integrin, natalizumab is thought to stop the leucocytes from going from the blood into the brain.

cynomolgus pērtiķiem, kuriem līdz dzemdībām tika ievadīts natalizumabs, tika konstatēta neliela natalizumaba koncentrācija mātes pienā.
in cynomolgus monkeys treated with natalizumab until parturition, low levels of natalizumab were detected in the breast milk of some animals.

natalizumabs nedemonstrēja efektu uz in vitro α4- integrīna-pozitīvās audzēju līnijas šūnu proliferāciju vai citotoksicitāti.
natalizumab showed no effects on in vitro assays of α4-integrin-positive tumour line proliferation or cytotoxicity.

natalizumabs bloķē α4β7 integrīna mijiedarbību ar tā gļotādu šūnu adhēzijas molekulu-1 (madcam-1).
natalizumab blocks the interaction of α4β7 integrin with the mucosal addressin cell adhesion molecule-1 (madcam-1).

natalizumabs bloķē α4β7 integrīna mijiedarbību ar tā gļotādu šūnau adhēzijas molekulu- 1 (madcam- 1).
natalizumab blocks the interaction of α 4β 7 integrin with the mucosal addressin cell adhesion molecule-1 (madcam-1).

natalizumabs ir humanizētas anti-α4-integrīna antivielas rekombinants, kas iegūts no peļu šūnu līnijas, izmantojot dns rekombinanto tehnoloģiju.
natalizumab is a recombinant humanised anti-α4-integrin antibody produced in a murine cell line by recombinant dna technology.

atšķaidot (skatīt 6.6. apakšpunktu) infūziju šķīdums satur apmēram 2,6 mg/ml natalizumaba.
when diluted (see section 6.6), the solution for infusion contains approximately 2.6 mg/ml of natalizumab.